Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14924966 | 0.91 | RAB9A (0.51) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL14924983 | 0.90 | MEN1 (0.49) | ALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL14924911 | 0.87 | ALDH1A1 (0.58) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL5002692 | 0.85 | KMT2A (0.54) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL14924932 | 0.82 | MAPT (0.51) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL5002691 | 0.82 | MAPK1 (0.51) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL14925015 | 0.80 | MAPT (0.44) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL14924960 | 0.77 | ALDH1A1 (0.54) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL14924948 | 0.76 | GAA (0.55) | ALDH1A1MAPK1SMN1; SMN2LMNAMAPT | |
| SCHEMBL21644604 | 0.75 | NPC1 (0.57) | MAPK1SMN1; SMN2LMNAKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130116251-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116253-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116431-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116252-A1 | Novel HSP90 Inhibitor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116252-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | ALDH1A1 873/4885MAPK1 287/4885SMN1; SMN2 4619/4885 |
| US-20130116253-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | ALDH1A1 873/4885MAPK1 287/4885SMN1; SMN2 4619/4885 |
| US-20130116251-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | ALDH1A1 873/4885MAPK1 287/4885SMN1; SMN2 4619/4885 |
| US-20130116431-A1 | Novel HSP90 Inhibitor | HSP90AB1, HSP90AB2P, HSP90B1 | ALDH1A1 873/4885MAPK1 287/4885SMN1; SMN2 4619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.